Back
Intra-Cellular Therapies Stock Predictions
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
54
ITCI
Intra-Cellular Therapies
Last Price:
85.40
Seasonality Move:
25.32%
7 Day Trial
ALL ACCESS PASS
$
7
How to Build the Ultimate Dividend Portfolio
See how to build your own Ultimate Dividend PortfolioIntra-Cellular Therapies Stock Forecast
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 46.8% based on the past 10 years of stock performance.
- Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $84.75. The Score for ITCI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 46.8% based on the past 10 years of stock performance.
Intra-Cellular Therapies Stock Rating
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies overpriced?
- Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
88.00
52-Week Low:
50.87
Prediction Charts
Market Cap:
8.98B
Price in USD:
84.75
Volume:
1.04M
Beta:
1.05
Technical Analysis
SMA50:
74.90
SMA100:
74.72
SMA200:
71.73
52-Wk Change:
70.32%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company. -
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 84.75 USD today. -
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-11 | 73.70 | 75.76 | 76.19 | 73.70 |
| Oct-14 | 76.02 | 73.84 | 76.14 | 73.76 |
| Oct-15 | 73.91 | 74.71 | 75.12 | 73.82 |
| Oct-16 | 75.10 | 76.09 | 76.55 | 74.59 |
| Oct-18 | 78.22 | 78.34 | 79.46 | 78.04 |
| Oct-21 | 77.94 | 76.91 | 78.47 | 76.56 |
| Oct-22 | 76.52 | 77.09 | 78.03 | 76.17 |
| Oct-23 | 76.52 | 75.02 | 76.98 | 74.76 |
| Oct-24 | 75.22 | 75.64 | 76.04 | 74.80 |
| Oct-25 | 75.60 | 75.81 | 76.87 | 75.25 |
| Oct-28 | 75.93 | 76.82 | 77.05 | 75.58 |
| Oct-29 | 77.24 | 76.75 | 78.02 | 75.57 |
| Oct-30 | 78.89 | 85.46 | 88.00 | 76.76 |
| Oct-31 | 85.01 | 84.75 | 86.88 | 84.57 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and an increase next year of $1.08 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.